Literature DB >> 19784821

Uric acid is an independent predictor of arterial stiffness in hypertensive patients.

Wei-Chuan Tsai1, Yao-Yi Huang, Chih-Chan Lin, Wei-Ting Li, Cheng-Han Lee, Ju-Yi Chen, Jyh-Hong Chen.   

Abstract

Increased arterial stiffness is an important marker for target organ damage in essential hypertension. Both serum uric acid (UA) and C-reactive protein (CRP) were reported to be associated with target organ damage. However, the influences of UA and CRP on large arterial stiffness were not well elucidated. This study included 200 essential hypertension patients (64 women) whose age was between 20 and 50 years old (mean age 41 +/- 8 years). None of the patients had diabetes mellitus or overt end-organ damage. Arterial stiffness was assessed by pulse-wave velocity (PWV) measured by tonometry from carotid to radial artery. Serum UA, high-sensitivity CRP (hsCRP), glucose, insulin, and lipid profiles were measured at the same time in each patient. PWV levels were significantly correlated with mean blood pressure (r = 0.245, P < 0.001), diastolic blood pressure (r = 0.323, P < 0.001), high-density lipoprotein (r = -0.169, P = 0.016), and UA (r = 0.234, P = 0.001), but not age, body mass index, blood sugar, insulin, low-density lipoprotein, triglyceride, and hsCRP. Pulse-wave velocity levels were significantly higher in males (8.9 +/- 1.2 vs 8.2 +/- 1.2 m/s, P < 0.001) and smokers (9.3 +/- 1.1 vs 8.5 +/- 1.2 m/s, P < 0.001). Uric acid was significantly correlated with hsCRP (r = 0.294, P < 0.001). After multivariate analysis controlling for all possible confounding factors, UA (odds ratio 1.28, 95% confidence interval 1.02-1.61, P = 0.032) was still independently associated with increased PWV. In conclusion, UA but not hsCRP was independently associated with increased PWV in essential hypertension. Although UA was correlated with hsCRP, the association between UA and PWV was not through the effect of enhanced inflammation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19784821     DOI: 10.1007/s00380-008-1127-9

Source DB:  PubMed          Journal:  Heart Vessels        ISSN: 0910-8327            Impact factor:   2.037


  27 in total

Review 1.  Serum uric acid and cardiovascular disease: recent developments, and where do they leave us?

Authors:  Joshua F Baker; Eswar Krishnan; Lan Chen; H Ralph Schumacher
Journal:  Am J Med       Date:  2005-08       Impact factor: 4.965

Review 2.  C-reactive protein: a family of proteins to regulate cardiovascular function.

Authors:  Susanne B Schwedler; János G Filep; Jan Galle; Christoph Wanner; Lawrence A Potempa
Journal:  Am J Kidney Dis       Date:  2006-02       Impact factor: 8.860

3.  Serum uric acid and target organ damage in primary hypertension.

Authors:  Francesca Viazzi; Denise Parodi; Giovanna Leoncini; Angelica Parodi; Valeria Falqui; Elena Ratto; Simone Vettoretti; Gian Paolo Bezante; Massimo Del Sette; Giacomo Deferrari; Roberto Pontremoli
Journal:  Hypertension       Date:  2005-03-21       Impact factor: 10.190

4.  Relation between serum uric acid and risk of cardiovascular disease in essential hypertension. The PIUMA study.

Authors:  P Verdecchia; G Schillaci; G Reboldi; F Santeusanio; C Porcellati; P Brunetti
Journal:  Hypertension       Date:  2000-12       Impact factor: 10.190

5.  Relationship of serum uric acid to measures of endothelial function and atherosclerosis in healthy adults.

Authors:  D Erdogan; H Gullu; M Caliskan; E Yildirim; M Bilgi; T Ulus; N Sezgin; H Muderrisoglu
Journal:  Int J Clin Pract       Date:  2005-11       Impact factor: 2.503

6.  Relationships of C-reactive protein, uric acid, and glomerular filtration rate to arterial stiffness in Japanese subjects.

Authors:  Y Saijo; M Utsugi; E Yoshioka; N Horikawa; T Sato; Y Y Gong; R Kishi
Journal:  J Hum Hypertens       Date:  2005-11       Impact factor: 3.012

7.  Uric acid level as a risk factor for cardiovascular and all-cause mortality in middle-aged men: a prospective cohort study.

Authors:  Leo K Niskanen; David E Laaksonen; Kristiina Nyyssönen; Georg Alfthan; Hanna-Maaria Lakka; Timo A Lakka; Jukka T Salonen
Journal:  Arch Intern Med       Date:  2004-07-26

8.  Noninvasively assessed pulsatility of ascending aortic pressure waveform is associated with the presence of coronary artery narrowing.

Authors:  Andrzej Wykretowicz; Lidia Metzler; Agata Milewska; Marek Balinski; Agnieszka Rutkowska; Karolina Adamska; Tomasz Krauze; Przemysław Guzik; Mieczysław Dziarmaga; Henryk Wysocki
Journal:  Heart Vessels       Date:  2008-02-14       Impact factor: 2.037

9.  Hyperuricemia, low urine urate excretion and target organ damage in arterial hypertension.

Authors:  Carlos Campo; Luis M Ruilope; Julian Segura; José L Rodicio; Rafael García-Robles; Juan Garcia-Puig
Journal:  Blood Press       Date:  2003       Impact factor: 2.835

10.  Effect of hyperuricemia upon endothelial function in patients at increased cardiovascular risk.

Authors:  Giuseppe Mercuro; Cristiana Vitale; Elena Cerquetani; Sandra Zoncu; Martino Deidda; Massimo Fini; Giuseppe M C Rosano
Journal:  Am J Cardiol       Date:  2004-10-01       Impact factor: 2.778

View more
  22 in total

1.  Effects of cold pressor-induced sympathetic stimulation on the mechanical properties of common carotid and femoral arteries in healthy males.

Authors:  Jie Liu; Tie-Sheng Cao; Yun-You Duan; Yi-Lin Yang; Li-Jun Yuan
Journal:  Heart Vessels       Date:  2010-12-22       Impact factor: 2.037

2.  Reduced renal function is associated with combined increases in ventricular-systolic stiffness and arterial load in patients undergoing cardiac catheterization for coronary artery disease.

Authors:  Hidekatsu Fukuta; Nobuyuki Ohte; Kazuaki Wakami; Kaoru Asada; Toshihiko Goto; Seiji Mukai; Genjiro Kimura
Journal:  Heart Vessels       Date:  2010-10-16       Impact factor: 2.037

3.  Presence of tophi is a predictive factor of arterial stiffness in patients with gout.

Authors:  WooSeong Jeong; Seung-Jae Joo; Jinsoek Kim; Jae-Geun Lee; Joon Hyouk Choi
Journal:  Rheumatol Int       Date:  2019-06-01       Impact factor: 2.631

4.  Clinical analysis of the risk factors of slow coronary flow.

Authors:  Shuang Xia; Song-Bai Deng; Yang Wang; Jun Xiao; Jian-Lin Du; Yu Zhang; Xi-Chun Wang; Ye-Qing Li; Rui Zhao; Li He; Yu-Luan Xiang; Qiang She
Journal:  Heart Vessels       Date:  2011-01-05       Impact factor: 2.037

5.  Sleep apnea is a stronger predictor for coronary heart disease than traditional risk factors.

Authors:  Denis Martinez; Cristini Klein; Laura Rahmeier; Roberto Pacheco da Silva; Cintia Zappe Fiori; Cristiane Maria Cassol; Sandro Cadaval Gonçalves; Angelo Jose Goncalves Bos
Journal:  Sleep Breath       Date:  2011-07-28       Impact factor: 2.816

6.  Association of Uric Acid With Vascular Stiffness in the Framingham Heart Study.

Authors:  Tapan Mehta; Eugene Nuccio; Kim McFann; Magdalena Madero; Mark J Sarnak; Diana Jalal
Journal:  Am J Hypertens       Date:  2014-12-31       Impact factor: 2.689

7.  Associations of serum uric acid levels with arterial wave reflections and central systolic blood pressure.

Authors:  Pai-Feng Hsu; Shao-Yuan Chuang; Hao-Min Cheng; Shih-Hsien Sung; Chih-Tai Ting; Edward G Lakatta; Frank C P Yin; Pesus Chou; Chen-Huan Chen
Journal:  Int J Cardiol       Date:  2013-02-27       Impact factor: 4.164

Review 8.  The Impacts of Serum Uric Acid on arterial hemodynamics and Cardiovascular Risks.

Authors:  Pai-Feng Hsu; Shao-Yuan Chuang; Wen-Chung Yu; Hsin-Bang Leu; Wan-Leong Chan; Chen-Huan Chen
Journal:  Acta Cardiol Sin       Date:  2013-03       Impact factor: 2.672

9.  Longitudinal Association Between Serum Uric Acid and Arterial Stiffness: Results From the Baltimore Longitudinal Study of Aging.

Authors:  Marco Canepa; Francesca Viazzi; James B Strait; Pietro Ameri; Roberto Pontremoli; Claudio Brunelli; Stephanie Studenski; Luigi Ferrucci; Edward G Lakatta; Majd AlGhatrif
Journal:  Hypertension       Date:  2016-12-12       Impact factor: 10.190

10.  Serum uric Acid level and diverse impacts on regional arterial stiffness and wave reflection.

Authors:  Suyan Bian; Hongyang Guo; Ping Ye; Leiming Luo; Hongmei Wu; Wenkai Xiao
Journal:  Iran J Public Health       Date:  2012-08-31       Impact factor: 1.429

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.